ICD in the context of abnormal troponin: Difference between revisions
Jump to navigation
Jump to search
Dima Nimri (talk | contribs) Created page with "__NOTOC__ {{Implantable Cardioverter Defibrillator ACC/AHA/HRS Guidelines}} {{CMG}}; {{AE}}{{DN}} ===ICD IMPLANTATION IN THE CONTEXT OF AN ABNORMAL TROPONIN THAT IS NOT DUE T..." |
Dima Nimri (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{DN}} | {{CMG}}; {{AE}}{{DN}} | ||
==ICD IMPLANTATION IN THE CONTEXT OF AN ABNORMAL TROPONIN THAT IS NOT DUE TO A MYOCARDIAL INFARCTION== | |||
{|class="wikitable" | {|class="wikitable" | ||
Revision as of 17:27, 26 October 2016
| ICD Guidelines Microchapters |
| Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities |
| Expert Consensus on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials |
|
ICD Implantation in the Context of an Abnormal Troponin that is Not Due to a Myocardial Infarction |
|
ICD Implantation Less Than 9 Months From The Initial Diagnosis of Nonischemic Cardiomyopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
ICD IMPLANTATION IN THE CONTEXT OF AN ABNORMAL TROPONIN THAT IS NOT DUE TO A MYOCARDIAL INFARCTION
| Recommended |
| "1. In patients with abnormal cardiac biomarkers that are not thought to be due to an MI and who otherwise would be candidates for implantation on the basis of primary prevention or secondary prevention criteria, implantation of an ICD is recommended." |